Ceribell is one of the most commercially successful rapid-EEG companies, with a point-of-care system enabling seizure detection in minutes rather than hours, directly addressing ICU bottlenecks. Its FDA-cleared AI + hardware stack and strong hospital adoption position it as a category leader in acute neurodiagnostics.